Hydrogenics Corporation (USA) (NASDAQ:HYGS), the hydrogen power specialist reported wider-than-expected quarterly losses. For the third quarter, the company reported a net loss of $0.13 per share, compared with a loss of $0.05 per share in the same period last year. Analysts expected a loss of $0.09 per share, according to Capital IQ estimates. Revenue grew 20% from Q3 2013 to $11.1 million, falling short of estimates of $13.1 million.Hydrogenics Corporation (USA) (NASDAQ:HYGS) president Daryl Wilson anticipates stronger growth in Q4 and in 2015. "We expect the fourth quarter's top line improvement to carry Hydrogenics over $50 million in revenue for the year, as previously forecast, on the back of higher electrolyzer and fuel cell shipments," he said in a statement. Analysts expect 2014 revenue of $52 million.Ares Commercial Real Estate Corp (NYSE:ACRE) reported Q3 financial results on Monday with net income falling short of analysts' estimates on revenues that beat the consensus. Q3 net income fell to $4.1 million, or $0.14 per diluted share, from $6.9 million, or $0.25 per diluted share, missing the Street forecast of $0.22 per share. The real estate investment trust said quarterly revenues climbed to $15 million from $12.6 million and beat the consensus of $11.6 million. Ares Commercial Real Estate Corp (NYSE:ACRE) said it expects Q4 net earnings of $0.25-$0.28 per share, in line with the consensus estimate of $0.27 provided by Thomson Reuters. The company also declared a quarterly dividend of $0.25 per share, unchanged relative to the previous dividend announcement. ACRE trades with a 52-week range of $11.41-$13.95.Dendreon Corporation (NASDAQ:DNDN), the prostate cancer drug developer said it reached a financial restructuring agreement with its senior notes holders, who hold about $521 million in debt, and announced it filed for Chapter 11 bankruptcy protection. The maker of Provenge, a prostate cancer treatment, said the restructuring will allow it to continue to provide the drug to doctors and patients. Dendreon also said it has enough liquidity to support all operations during the restructuring process. Dendreon Corporation (NASDAQ:DNDN) said it will try to find a buyer through a bidding process and that it will continue as a stand-along business if no qualified bids are received. Dendreon Corp. was expected to report quarterly results on Tuesday, Nov. 11. Analysts were expecting a loss of $0.10 per share on revenues of $78.7 million.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
